An Online Intervention Promoting HPV Vaccination Among Chinese MSM

NCT ID: NCT04815837

Last Updated: 2021-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-01

Study Completion Date

2021-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hong Kong Chinese speaking men who have sex with men completed a baseline survey, and then received an online intervention promoting uptake of Human Papillomavirus (HPV) vaccination. All participants are followed up by telephone 12 months after the completion of baseline survey.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this study is to investigate prevalence of uptake of Human Papillomavirus (HPV) vaccination after exposure to health promotion among men who have sex with men in Hong Kong within a 12-month project period.

Inclusion criteria are Hong Kong Chinese speaking males aged 18-45 years old and self-reported having had oral or anal intercourse with at least one man in the last six months. Those who have ever received HPV vaccination are excluded.

Participants are recruited through outreaching in gay venues, online advertisement and referral made by peers and non-governmental organization. With verbal informed consent, participants completed a baseline survey through telephone. They are then exposed to online interventions including: 1) watching an online video, 2) receiving a discount coupon to receive HPV vaccination at collaborative private clinics, 3) visiting the project webpage, and 4) receiving follow-up reminders 1, 2, 4, 6, and 8 months after the baseline survey.

All participants are followed up by telephone 12 months after the baseline survey to access the primary outcome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccine Refusal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Participants received the following interventions:

1. Viewing a video promoting Human Papillomavirus (HPV) vaccination
2. Receiving discount coupons
3. Visiting the project webpage
4. Receiving follow-up reminders

Group Type EXPERIMENTAL

Intervention

Intervention Type BEHAVIORAL

1. Viewing a video promoting Human Papillomavirus (HPV) vaccination: participants will watch a 5-minute online video promoting MSM's uptake of HPV vaccination. In the video, a peer MSM discussed about the risk of contracting HPV and having anal cancers among MSM, severe consequences of HPV-related diseases, as well as the benefits of HPV vaccination. He also demonstrated the procedures of taking up HPV vaccination in the collaborative private clinics, which portrayed caring, privacy guaranteed, and non-judgmental environment.
2. Receiving the discount coupons: each participant will be given a discount coupon. By using the coupon, one can enjoy a 10% discount for taking up three doses of HPV vaccines at a collaborating private clinic.
3. Visiting the project webpage: Participants can assess the project webpage by scanning the QR code on the discount coupon.
4. Follow-up reminders: participants received five reminders at Month 1, 2, 4, 6, \& 8.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention

1. Viewing a video promoting Human Papillomavirus (HPV) vaccination: participants will watch a 5-minute online video promoting MSM's uptake of HPV vaccination. In the video, a peer MSM discussed about the risk of contracting HPV and having anal cancers among MSM, severe consequences of HPV-related diseases, as well as the benefits of HPV vaccination. He also demonstrated the procedures of taking up HPV vaccination in the collaborative private clinics, which portrayed caring, privacy guaranteed, and non-judgmental environment.
2. Receiving the discount coupons: each participant will be given a discount coupon. By using the coupon, one can enjoy a 10% discount for taking up three doses of HPV vaccines at a collaborating private clinic.
3. Visiting the project webpage: Participants can assess the project webpage by scanning the QR code on the discount coupon.
4. Follow-up reminders: participants received five reminders at Month 1, 2, 4, 6, \& 8.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hong Kong Chinese speaking males aged 18-45 years old and self-reported having had oral or anal intercourse with at least one man in the last six months

Exclusion Criteria

* Have received any HPV vaccination
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chinese University of Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zixin Wang

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zixin Wang, PhD

Role: PRINCIPAL_INVESTIGATOR

Chinese University of Hong Kong

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre for Health Behaviours Research, the Chinese University of Hong Kong

Hong Kong, , Hong Kong

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KPF18HLF22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Child Vaccination Scheduling in China
NCT07141875 NOT_YET_RECRUITING